Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
Reported Late Monday, Molecular Partners Presents New Preclinical Data Supporting Its MP0533 DARPin T-Cell Engager For The Treatment Of AML
New data indicates potential to expand the therapeutic window and improve safety compared to existing T-cell engagers
Tri-specific T-cell engager resulted in AML cell-specific cytotoxicity with minimal
Molecular Partners Presents Interim Safety And Mechanistic Data From Ongoing Phase 1 Trial Of MP0317 For Treatment of Solid Tumors
First clinical observation of tumor localized CD40 activation provided by MP0317
No systemic or dose-limiting toxicities observed, a key parameter for CD40 agents
Dose escalation remains ongoing with study
SVB Leerink Downgrades Molecular Partners to Market Perform, Lowers Price Target to $8
SVB Leerink analyst Daina Graybosch downgrades Molecular Partners (NASDAQ:MOLN) from Outperform to Market Perform and lowers the price target from $30 to $8.